Each week we’ll post a roundup of the news and announcements from the pharma industry including EC & FDA Drug Approvals, updates on biosimilars and further industry reading, to keep you up-to-date on all the activity from the week!
This Week
Companies include: AstraZeneca, Daiichi-Sankyo, GSK, Janssen, Johnson & Johnson, Novartis, Novo Nordisk, Pfizer, Roche and Takeda Ireland
Week ending 19th February, 2021
February 2021
Companies include: AstraZeneca, Bristol-Myers Squibb, Janssen, Lilly, Novo Nordisk, Pfizer, Regeneron, Sanofi and ViiV Healthcare
Week Ending 12th February, 2021
Companies include: AstraZeneca, Bayer, Janssen, Jazz Pharmaceuticals, MSD, Novartis, Novo Nordisk, Pfizer and Regeneron
Week Ending 5th February, 2021
January 2021:
Companies include: Abbvie, Amgen, AstraZeneca, BMS, Eli Lilly, Gilead, Janssen, Merck, Moderna, MSD, Mundipharma, Pfizer, Regeneron, Roche, Sanofi
Week Ending 29th January, 2021
———-
2020
Companies include: Abbvie, AstraZeneca, Bayer, Grünenthal, Janssen, Merck, Novartis, Pfizer, Regeneron, Sanofi
Week Ending 4th December, 2020
Companies include: AstraZeneca, Bristol Meyers Squibb, Janssen, Moderna, Pfizer, Sanofi, Teva, Uniphar, Vertex
Week Ending 27th November, 2020
Companies included: AbbVie, AstraZeneca, BioNTech, Eli Lilly, Gilead, GSK, Moderna, Pfizer, Novo Nordisk Roche Sanofi, ViiV Healthcare
Week ending 20th November, 2020
Companies included: Abbvie, Amgen, AstraZeneca, Bristol Meyers Squibb, Eli Lilly, GSK, Pfizer, Menarini, Novo Nordisk
Week ending 13th November, 2020
October
Companies included: Abbvie, AstraZeneca, Bayer, Biogen, Bristol Meyers Squibb, Daiichi, Gilead, MSD, Perrigo, Pfizer, Novartis, Sanofi
Week Ending 30th October, 2020
Companies included: Abbvie, Astellas, AstraZeneca, Gilead, GSK, Janssen, MSD, Mylan, Novartis, Pfizer, Sanofi
Week ending 23rd October, 2020
2019
Version 39 – 19th July, 2019
Companies mentioned: Allergan, Amgen, AstraZeneca, Bayer, Boehringer, GSK, Gilead Sciences, Mallinckrodt, MSD, Novartis, Novo Nordisk, Roche, Sanofi and Takeda
July 2019
Companies mentioned: Amgen, AstraZeneca, Bayer, Bristol-Meyers, Ferring, GSK, Janssen, MSD, Mundipharma, Novartis, Pfizer, Roche, Sanofi and Takeda
Companies Mentioned: AbbVie, Allergan, AstraZeneca, Bayer, Gilead, GSK, LEO Pharma, Mundipharma, Mylan, Pfizer, Novartis, Roche, Sanofi, Takeda
March 2019
Sláintecare Action Plan – 2019
Sláintecare article in Sunday Business Post – 17th March, 2019
Prof Michael Barry article – Sunday Business Post, March 3rd
February 2019
Companies Mentioned: Abbott, AbbVie, AstraZeneca, Bayer, Eli Lilly, IQVIA, MSD, Mylan, Novo Nordisk, Pfizer, Roche, Takeda
Companies Mentioned: Astellas, AstraZeneca, BMS, Celgene, GSK, Merck Group, MSD, Novartis, Perrigo, Pfizer, Roche and Vertex
January 2019
Version 33 – 25th January, 2019
Companies mentioned: Amgen, Astellas, GSK, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and Vertex
Version 32 – 18th January, 2019
Companies mentioned: Abbott, Amgen, Clonmel Healthcare, GSK, Merck, MSD, Mundipharma, Novartis, Pfizer, Roche, Shire, Takeda and UCB Pharma
Version 31 – 11th January 2019
Companies mentioned: Amgen, Mylan, Novartis, Pfizer, Sanofi, Shire, Takeda and Teva
Companies mentioned: Amgen, Boston Scientific, Bristol-Myers Squibb, Merck, Novartis, Pfizer and Teva
December 2018
Version 29 – 21st December, 2018
Companies mentioned: Amgen, GSK, Pfizer, MSD, Novartis, Recordati, Roche, Sanofi, Shire,Tesaro & Vertex
Versions 28 – 14th December, 2018
Companies Mentioned: Amgen, AstraZeneca, Genentech, Gilead, GSK, J&J, MSD, Novartis, Nuritas, Pfizer, Roche, Shire and Takeda
November 2018
Version 27 – w/e 30th November, 2018
Companies mentioned: AbbVie, Amgen, Astellas, Bayer, HealthBeacon, MSD, Mundipharma, Novo Nordisk, Novartis, Pfizer, Roche, Vertex
Version 26 – w/e 23rd November, 2018
Companies mentioned: Boston Scientific, Eli Lilly, GSK, hmR International, Janssen, MSD, Novartis, Pfizer, Recordati, Sanofi, Shire and Takeda
Version 25 – w/e 16th November, 2018
Companies mentioned: Amgen, AstraZeneca, Bristol-Meyers Squibb, GSK, Janssen, Merck Serono, MSD, Novartis, Pfizer, Samsung Pharmaceutical, Shire, Takeda and Vertex
Version 24 – w/e 9th November, 2018
Companies mentioned: Amgen, Astellas, AstraZeneca, GSK, Hitachi, Jazz Pharmaceuticals, Merck Group, MSD, Pfizer, Novartis, Roche, and Uniphar
Further reading:
Bruised, battered, but unbowed. Tony O’Brien’s interview with Susan Mitchell, Sunday Business Post
October 2018
Version 23 – w/e 26th October, 2018
Companies mentioned: Amgen, AstraZeneca, Eli Lilly, Lundbeck, MSD, Novartis, Pfizer, Shire, Takeda
Further reading:
- A possible “Humirageddon:” Perspectives on the EU biosimilar launch
- Agility: How Pharma Can Be Bolder, Faster, Better Whitepaper from eyeforpharma
Companies mentioned: AbbVie, Amgen, AstraZeneca, Eli Lilly, Gilead, GSK, Grünenthal, MSD Ireland, MSD, Novartis, Pfizer, Roche, Samsung Bioepis , Shire and ViiV Healthcare
Further reading:
• Tufts study uncovers the economic advantage of single-source drug development and manufacturing
• Fighting the Opioid epidemic: How Grünenthal’s abuse-deterrent technology contributes
Companies mentioned: Amgen, Bayer, Biogen, Gilead Sciences, GSK, MSD, Mundipharma, Mylan, Novartis, Pfizer, and Roche
Companies mentioned: Amgen, Astellas, Eli Lilly, GSK, Janssen, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, and Takeda
September 2018
Version 19 – w/e 28th September.
Companies mentioned: Amgen, Astellas, AstraZeneca, Biogen, CSL Behring, Eli Lilly, Ferring, GSK, Novartis, Pfizer, Roche, Sandoz, Shire and Takeda
Version 18 – w/e 21st September
Companies mentioned: Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, GSK, Janssen, MSD, Mylan, Novartis, Pfizer, Shire, Takeda and Teva
- Further reading:
- New HSE Chairman announced
- Overview of Diabetes Therapeutics Market
Version 17 – w/e 14th September
Companies mentioned: Amgen, AstraZeneca, Astellas, Bristol-Meyers Squibb, GSK, Janssen, MSD, Mylan, Novartis, Otsuka Pharmaceutical, Pfizer, Shire and Takeda
Further Reading:
- PARADIGMS study published
- India bans 328 combination drugs
- Five drugs manufactured in Ireland for the treatment of cancer and heart disease are not sanctioned for use here
- Novartis survey shows psoriasis patients want treatment effect beyond clear skin
Companies Mentioned: AstraZeneca, Bristol-Meyers Squibb, Celltrion Healthcare, Chanelle, GSK, Janssen, JW Pharmaceutical , Leo Pharma, MSD, Novartis, Pfizer, Sandoz, Sanofi and Shire
Further Reading:
-
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes
-
published March 2018
-
How Amazon could change the healthcare industry
-
• 90 Studies prove biosimilars’ safety and efficacy: What Now?
August 2018
Companies mentioned: Amgen, Bayer, Gilead, GSK, Jazz Pharmaceuticals, Johnson & Johnson, Leo Pharma, MSD, Novartis, Pfizer, Roche & Shire
Further reading:
- Sláintecare
- Brexit articles
- Big pharma takes a gamble on NHS experiment
Companies mentioned: Amgen, Astellas, AstraZeneca, Biontech, Eisai, GSK, MSD, Pfizer, Shire, Teva,and Uniphar Group
Further reading:
- Direct-to-consumer genetic testing
- Sláintecare
- Machine Learning in drug discovery & patient diagnosis
- UK Government set of guidelines re no-deal Brexit
Version 13 – Week Ending 17th August
Companies mentioned: Amgen, Astellas, AstraZeneca, Biogen, Bristol-Meyer-Squibb, GSK, Janssen, MSD, Mylan, Novartis, Novo Nordisk, PamEx, Pfizer, Regeneron, Roche, Teva,
Further reading:
- Report: pharma companies’ reputation among mental health patient groups
- Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L
- Article: Potential in oral delivery of biologics
- Blood marker that could predict the risk of developing kidney cancer
Version 12 – Week Ending 10th August
Companies mentioned: Merck, MSD Ireland, Mylan, Novartis, Perrigo, Pfizer and Sanofi
Version 11 – Week Ending 3rd August.
Companies mentioned: Aegerion Pharmaceuticals, Beats Medical, Leo Pharma, MSD, Novartis, Pfizer and Shire
July 2018
Version 10 – Week Ending 13th July
Companies mentioned: Bristol Myers-Squibbs, GSK, MSD, Mylan, Novartis, Pfizer, Shire and Takeda
Version 9 – Week Ending 6th July
Companies mentioned: Amgen, Ferring, GSK, PHA, MSD, Novartis, Pfizer, Sanofi and Shire.
June 2018
Version 8 – Week Ending 29th June
Companies mentioned: Amgen, AstraZeneca, Gilead, GSK, MSD, Novartis, Pfizer, Roche and Shire
Version 7 – Week Ending 22nd June
Companies mentioned: Amgen, Gilead, GSK, Janssen MSD, Mylan, Novartis, Novo Nordisk, Pfizer and Shire
Version 6 – Week Ending 15th June
Companies mentioned: Amgen, Astellas, AstraZeneca, BioMarin, GSK, MSD, Mylan, Novartis, Pfizer, Sanofi, Servier, Shire and Takeda
Version 5 – Week Ending 6th June,
Companies mentioned: Astellas, GSK, Mylan, Novartis, Pfizer, Sanofi, Shire and Takeda